BusinessUpdated 1 hr ago
Cancer drug price cap: Despite steepest cuts on generics, biosimilars, most patented, single-brand drugs keep their prices

35 drugs get cheaper across the board, 47 stay unchanged, and cuts reach 93% on some brands
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.


